Hester Biosciences Ltd (HESTERBIO) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 524669 | NSE: HESTERBIO | Pharmaceuticals & Drugs | Small Cap

Hester Biosciences Share Price

1,649 17.95 1.10%
as on 05-Dec'25 16:59

Hester Biosciences Ltd (HESTERBIO) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 524669 | NSE: HESTERBIO | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Hester Biosciences

Based on:

Overall Rating
Login to view analysis. Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Hester Biosciences stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
47.65
Market Cap:
1,387.5 Cr.
52-wk low:
1,246.8
52-wk high:
2,669

Is Hester Biosciences Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Hester Biosciences: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Hester Biosciences Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 21.8%24.2%26.3%31.2%19.7%23.3%17.3%11.9%9.3%10.6%-
Value Creation
Index
0.60.70.91.20.40.70.2-0.2-0.3-0.2-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 101123135171169208219254285286268
Sales YoY Gr.-22.2%9.3%27%-1%23.1%5.2%15.8%12.3%0.5%-
Adj EPS 22.829.335.850.935.751.645.436.931.537.134.2
YoY Gr.-28.7%22%42.4%-29.8%44.3%-11.9%-18.7%-14.6%17.6%-
BVPS (₹) 117.9143.5171.7210.9238.7279.3315.5343.7367.6398.6409.1
Adj Net
Profit
19.424.930.443.330.443.938.631.426.831.629
Cash Flow from Ops. 18.627.632.336.225.841.115.933.442.964-
Debt/CF from Ops. 2.11.41.31.11.90.47.74.93.11.6-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 12.3%11.1%9.3%0.5%
Adj EPS 5.6%0.8%-6.5%17.6%
BVPS14.5%10.8%8.1%8.4%
Share Price 11.1% -1.4% -4.2% -36.5%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
2122.422.726.615.919.915.311.28.99.78.5
Op. Profit
Mgn %
33.433.436.839.731.134.727.621.516.41817.6
Net Profit
Mgn %
19.220.222.625.3182117.612.49.41110.9
Debt to
Equity
0.40.30.30.20.20.10.50.60.40.30.1
Working Cap
Days
229217220208261245279292271252117
Cash Conv.
Cycle
16014014013416414516416815213155

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Hester Biosciences Ltd.

Standalone Consolidated
TTM EPS (₹) 34.2 51.5
TTM Sales (₹ Cr.) 268 300
BVPS (₹.) 409.1 397.2
Reserves (₹ Cr.) 339 329
P/BV 3.99 4.11
PE 47.65 31.65
From the Market
52 Week Low / High (₹) 1246.75 / 2669.00
All Time Low / High (₹) 0.25 / 3375.45
Market Cap (₹ Cr.) 1,388
Equity (₹ Cr.) 8.5
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Hester Biosciences:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Hester Biosciences - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Hester Biosciences

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales101123135171169208219254285286
Operating Expenses 678285103117136159199238236
Manufacturing Costs14121518191819202826
Material Costs203023292953648010094
Employee Cost 15182227373339485755
Other Costs 19222529323237515461
Operating Profit 33415068537261554751
Operating Profit Margin (%) 33.1%33.3%36.8%39.6%31.1%34.5%27.6%21.5%16.4%17.8%
Other Income 1123325655
Interest 4324542655
Depreciation 66589101010109
Exceptional Items 00000-50000
Profit Before Tax 25334460415553443742
Tax 681316101514121010
Profit After Tax 19253144314040322732
PAT Margin (%) 19.1%20.2%22.7%25.6%18.4%19.1%18.0%12.7%9.5%11.1%
Adjusted EPS (₹)22.629.335.951.636.746.946.538.031.937.4
Dividend Payout Ratio (%)18%18%28%21%18%21%22%21%19%19%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 100122146179203238268292313339
Share Capital 9999999999
Reserves 92114138171195229260284304331
Minority Interest0000000000
Debt3436393239410714110980
Long Term Debt131915117373837951
Short Term Debt2118242132233573029
Trade Payables6788141411293033
Others Liabilities 19131820212638849894
Total Liabilities 159178210240277282424546550546

Fixed Assets

Gross Block105110121162167165171199204212
Accumulated Depreciation4349546170788791100107
Net Fixed Assets 626167101978784108103105
CWIP 10213001482149171183
Investments 991428414465656565
Inventories34333948605771796959
Trade Receivables26273233454657828681
Cash Equivalents 511122512652
Others Assets 13161627284464575152
Total Assets 159178210240277282424546550546

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 19283236264116334364
PBT 25334460415553443742
Adjustment 9978122012151316
Changes in Working Capital -10-7-9-16-16-20-33-17416
Tax Paid -6-7-9-16-11-13-16-8-11-10
Cash Flow From Investing Activity -6-15-26-25-21-4-111-72-21-19
Capex -60-21-12-7-4-90-73-22-20
Net Investments 00-0-1-21-20000
Others 0-16-5-12-12-10021
Cash Flow From Financing Activity -12-6-6-20-1-419541-24-46
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing -26-4-3-1-27312-3-28
Interest Paid -4-3-2-4-4-4-1-10-13-13
Dividend Paid -5-4-6-10-7-6-9-9-7-5
Others -1-47-311-303248-2-1
Net Cash Flow 16-0-93-403-2-1

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)20.8322.4322.7926.9416.3318.1115.6211.538.989.77
ROCE (%)21.7924.1626.2831.1519.7423.2817.3111.919.2610.59
Asset Turnover Ratio0.690.740.70.760.650.750.630.530.520.52
PAT to CFO Conversion(x)11.121.030.820.841.030.41.031.592
Working Capital Days
Receivable Days7877796983798599108106
Inventory Days1119797931171031051079481
Payable Days978112099135947291107121

Hester Biosciences Ltd Stock News

Hester Biosciences Ltd FAQs

The current trading price of Hester Biosciences on 05-Dec-2025 16:59 is ₹1,649.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Hester Biosciences stood at ₹1,387.5.
The latest P/E ratio of Hester Biosciences as of 04-Dec-2025 is 47.65.
The latest P/B ratio of Hester Biosciences as of 04-Dec-2025 is 3.99.
The 52-week high of Hester Biosciences is ₹2,669 and the 52-week low is ₹1,246.8.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Hester Biosciences is ₹267.6 ( Cr.) .

About Hester Biosciences Ltd

Hester Biosciences was incorporated on April 29, 1987 as a Private Limited Company by the name of Hester Pharmaceuticals Limited. It was subsequently converted into a Public Limited Company on November 1, 1993. The company is engaged in the manufacturing of poultry vaccines. The company has been promoted by Rajiv D. Gandhi his brother Sanjiv D. Gandhi and Dr. Bhupendra V. Gandhi. The company changed its name to the present in 2008.

The company is a 100% biotech company producing animal biologicals. Located near the city of Ahmedabad, in the state of Gujarat, in Western India, Hester has a state-of-the-art facility to produce live and killed (Inactivated) veterinary vaccines.

Production procedures for poultry vaccines based on in-house advanced capabilities are being followed in the areas of virus propagation in specific pathogen-free embryos, tissue culture, batch fermentation of bacteria, lyophilisation and emulsion preparation.

Hester on December 22, 2008 launched a poultry vaccine against Coryza disease in chicken, containing 3 serotypes – A, B & C.

Hester is the first company in India to manufacture the Coryza vaccine with 3 strains as against other companies manufacturing the vaccine with only 2 serotypes - A & C. Coryza disease is of economical importance to poultry farmers as it causes a drop in egg production in laying birds.

Hester currently manufactures 39 types of poultry vaccines against various poultry diseases.

Product range of the company includes:

  • Live Vaccines
  • Killed Vaccines
  • Diagnostic kits &  Seromonitoring services

Achievements/ recognition:

  • GMP and ISO 9001:2000 certified company
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×